{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:13:53Z","timestamp":1787498033118,"version":"build-2736575974"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T00:00:00Z","timestamp":1590019200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Practical Laboratory Medicine"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.plabm.2020.e00169","type":"journal-article","created":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T11:40:29Z","timestamp":1591011629000},"page":"e00169","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["QbD based development of HPLC method for simultaneous quantification of Telmisartan and Hydrochlorothiazide impurities in tablets dosage form"],"prefix":"10.1016","volume":"21","author":[{"given":"Ashok K.","family":"Palakurthi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thirupathi","family":"Dongala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshmi Narasimha R.","family":"Katakam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.plabm.2020.e00169_bib2","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.aca.2005.03.004","article-title":"Development and validation of liquid chromatography\u2013mass spectrometry method for the determination of telmisartan in human plasma","volume":"540","author":"Chen","year":"2005","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.plabm.2020.e00169_bib3","first-page":"19","article-title":"Simultaneous HPLC\u2013UV analysis of telmisartan and hydrochlorothiazide in human plasma","volume":"49","author":"Ismail Salama","year":"2011","journal-title":"Bullet. Facul. Pharm."},{"key":"10.1016\/j.plabm.2020.e00169_bib4","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.jpba.2008.08.021","article-title":"Liquid chromatographic-tandem mass spectrometric method for the simultaneous quantitation of telmisartan and hydrochlorothiazide in human plasma","volume":"48","author":"Yan","year":"2008","journal-title":"J.\u00a0Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.plabm.2020.e00169_bib5","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.jpba.2008.08.021","article-title":"Liquid chromatographic\u2013tandem mass spectrometric method for the simultaneous quantitation of telmisartan and hydrochlorothiazide in human plasma","volume":"48","author":"Yan","year":"2008","journal-title":"J.\u00a0Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.plabm.2020.e00169_bib6","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jpha.2017.06.001","article-title":"Application of an LC\u2013MS\/MS method for the analysis of amlodipine, valsartan and hydrochlorothiazide in polypill for a bioequivalence study","volume":"7","author":"Jaivik","year":"2017","journal-title":"J.\u00a0Pharm. Anal."},{"key":"10.1016\/j.plabm.2020.e00169_bib7","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.talanta.2010.10.011","article-title":"Simultaneous determination of ramipril, ramiprilat and telmisartan in human plasma using liquid chromatography tandem mass spectrometry","volume":"83","author":"Gupta","year":"2011","journal-title":"Talanta"},{"key":"10.1016\/j.plabm.2020.e00169_bib8","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.farmac.2005.06.009","article-title":"Application of first-derivative, ratio derivative spectrophotometry, TLC-densitometry and spectrofluorimetry for the simultaneous determination of telmisartan and hydrochlorothiazide in pharmaceutical dosage forms and plasma","volume":"60","author":"Lories","year":"2005","journal-title":"Il Farmaco"},{"key":"10.1016\/j.plabm.2020.e00169_bib9","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jpba.2009.04.015","article-title":"Determination of losartan, telmisartan, and valsartan by direct injection of human urine into a column-switching liquid chromatographic system with fluorescence detection","volume":"50","author":"Brunetto","year":"2009","journal-title":"J.\u00a0Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.plabm.2020.e00169_bib10","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0731-7085(02)00643-X","article-title":"Simultaneous determination of hydrochlorothiazide and several angiotensin-II-receptor antagonists by capillary electrophoresis","volume":"26","author":"Hillaert","year":"2003","journal-title":"J.\u00a0Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.plabm.2020.e00169_bib11","first-page":"3","article-title":"Simultaneous determination of related substances of telmisartan and hydrochlorothiazide in tablet dosage form by using reversed phase high performance liquid chromatographic method","volume":"3","author":"Mukhopadhyay","year":"2011","journal-title":"J.\u00a0Pharm. Bioanal. Sci."},{"key":"10.1016\/j.plabm.2020.e00169_bib12","first-page":"145","article-title":"Development and validation of stability indicating HPLC method for the determination of process and degradation related impurities in telmisartan drug substance","volume":"3","author":"Balakrishna","year":"2019","journal-title":"Chem. Method."},{"key":"10.1016\/j.plabm.2020.e00169_bib13","first-page":"2","article-title":"Stability indicating UPLC method for the estimation of telmisartan related substances in tablets formulation","volume":"3","author":"Bhavani","year":"2013","journal-title":"Int. J. Sci. Res. Publ."},{"key":"10.1016\/j.plabm.2020.e00169_bib14","first-page":"1780","article-title":"ICH Harmonised Tripartite Guideline Validation of analytical procedures: text and methodology Q2 (R1)","year":"2005"},{"key":"10.1016\/j.plabm.2020.e00169_bib15","first-page":"593","article-title":"Development and validation of a stability-indicating LC method for simultaneous determination of related compounds of guaifenesin, terbutaline sulfate and ambroxol HCl in cough syrup formulation","volume":"18","author":"Rao","year":"2014","journal-title":"J.\u00a0Saudi Chem. Soc."},{"key":"10.1016\/j.plabm.2020.e00169_bib16","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40543-019-0171-7","article-title":"A\u00a0novel UPLC-PDA isocratic method for the quantification fulvestrant in oil-based pre-filled syringe injection matrix formulations","volume":"10","author":"Dongala","year":"2019","journal-title":"J.\u00a0Anal. Sci.Tech."},{"issue":"1","key":"10.1016\/j.plabm.2020.e00169_bib17","first-page":"5","article-title":"Stability-Indicating method for simultaneous determination of polar and non-polar related compounds of Zidovudine in drug substance and drug product tablet form","volume":"6","author":"Rao","year":"2015","journal-title":"Int. J. Res. Pharm. Sci."},{"issue":"8","key":"10.1016\/j.plabm.2020.e00169_bib18","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s10337-017-3339-6","article-title":"Development and validation of a stability-indicating LC method for determination of bexarotene in softgel dosage formulation","volume":"80","author":"Rao","year":"2017","journal-title":"Chromatographia"},{"key":"10.1016\/j.plabm.2020.e00169_bib19","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.13005\/ojc\/330349","article-title":"Simultaneous determination of related organic impurities of ibuprofen and paracetamol in combination solid dosage form by Rp-hplc with Qbd approach","volume":"33","author":"Ashok","year":"2017","journal-title":"Orient. J. Chem."},{"key":"10.1016\/j.plabm.2020.e00169_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.4827","article-title":"A\u00a0novel RP-HPLC refractive index detector method development and validation for determination of trace-level alcohols (un-sulfated) in sodium lauryl sulfate raw material","author":"Katakam","year":"2020","journal-title":"Biomed. Chromatogr."},{"issue":"5","key":"10.1016\/j.plabm.2020.e00169_bib21","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1080\/22297928.2019.1696701","article-title":"RP-HPLC stability indicating method development and validation of pseudoephedrine sulfate and related organic impurities in tablet dosage forms, robustness by QbD approach","volume":"9","author":"Dongala","year":"2019","journal-title":"Anal. Chem. Lett."},{"issue":"4","key":"10.1016\/j.plabm.2020.e00169_bib22","first-page":"473","article-title":"Simultaneous estimation of fluticasone propionate, azelastine hydrochloride, phenylethyl alcohol and benzalkonium chloride by RP-HPLC method in nasal spray preparations","volume":"1","author":"Rao","year":"2010","journal-title":"Int. J. Res. Pharm. Sci."},{"key":"10.1016\/j.plabm.2020.e00169_bib23","first-page":"497","article-title":"Stability-indicating hplc method for simultaneous estimation of low level impurities of telmisartan and hydrochlorothiazide in tablet dosage forms","volume":"4","author":"Rama Mohana Reddy","year":"2012","journal-title":"Int. J. Pharm. Pharmaceut. Sci."},{"key":"10.1016\/j.plabm.2020.e00169_bib24","doi-asserted-by":"crossref","DOI":"10.1080\/10826076.2013.765457","article-title":"Reversed phase liquid chromatographic method development in analytical quality by design framework","author":"Reid","year":"2013","journal-title":"J.\u00a0Liq. Chromatogr. Relat. Technol."},{"key":"10.1016\/j.plabm.2020.e00169_bib25","series-title":"RSM Simplified: Optimizing Processes Using Response Surface Methods for Design of Experiments","author":"Anderson","year":"2004"},{"key":"10.1016\/j.plabm.2020.e00169_bib26","first-page":"48","article-title":"A\u00a0quality-by-design methodology for rapid LC method development","volume":"27","author":"Krull","year":"2009","journal-title":"LC-GC N. Am."},{"key":"10.1016\/j.plabm.2020.e00169_bib27","first-page":"594","article-title":"HPLC-UV method development for the determination of EDTA in oxycodone HCl oral liquids with derivatization technique. Robustness by design of experiments approach","volume":"5","author":"Dongala","year":"2019","journal-title":"Anal.Chem. Lett."},{"issue":"2011","key":"10.1016\/j.plabm.2020.e00169_bib28","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.jpba.2011.04.015","article-title":"Expanding the term \u2018\u2018Design Space\u2019\u2019 in high performance liquid chromatography (I)","volume":"56","author":"Monks","year":"2011","journal-title":"J.\u00a0Pharmaceut. Biomed. Anal."},{"issue":"10","key":"10.1016\/j.plabm.2020.e00169_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.4608","article-title":"Stability-indicating HPLC method for simultaneous quantification of 14 impurities in excedrin tablet formulations and identification of new impurity by LC\u2013MS in accelerated stability studies","volume":"33","author":"Dongala","year":"2019","journal-title":"Biomed. Chromatogr."},{"issue":"1","key":"10.1016\/j.plabm.2020.e00169_bib30","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3797\/scipharm.1210-18","article-title":"Development and validation of a stability-indicating LC-method for the simultaneous estimation of levodropropizine, chloropheniramine, methylparaben, propylparaben, and levodropropizine impurities","volume":"81","author":"Kumar","year":"2013","journal-title":"Sci. Pharm."},{"key":"10.1016\/j.plabm.2020.e00169_bib31","first-page":"48","article-title":"Photostability issues in pharmaceutical dosage forms and photostabilization","volume":"19","author":"Karthik","year":"2018","journal-title":"AAPS"},{"key":"10.1016\/j.plabm.2020.e00169_bib32","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1124\/jpet.119.256446","article-title":"Gellan gum based sol-to-gel transforming system of natamycin transfersomes improves topical ocular delivery","volume":"370","author":"Janga","year":"2019","journal-title":"J.Pharm. Exp. Ther."}],"container-title":["Practical Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352551719301477?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352551719301477?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T01:15:34Z","timestamp":1762478134000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352551719301477"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":31,"alternative-id":["S2352551719301477"],"URL":"https:\/\/doi.org\/10.1016\/j.plabm.2020.e00169","relation":{},"ISSN":["2352-5517"],"issn-type":[{"value":"2352-5517","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"QbD based development of HPLC method for simultaneous quantification of Telmisartan and Hydrochlorothiazide impurities in tablets dosage form","name":"articletitle","label":"Article Title"},{"value":"Practical Laboratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.plabm.2020.e00169","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"e00169"}}